We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+0.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.8B
AUM Growth
+$101M
(+0.45%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,075
New
272
Increased
822
Reduced
479
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$58.5M |
| 2 |
Constellation Brands
STZ
|
+$45.5M |
| 3 |
Aptiv
APTV
|
+$45.5M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$44.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$85M |
| 2 |
American Airlines Group
AAL
|
+$47.2M |
| 3 |
AES
AES
|
+$47M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$38.2M |
| 5 |
Edison International
EIX
|
+$37.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.12% |
| 2 | Healthcare | 14.68% |
| 3 | Technology | 14.21% |
| 4 | Industrials | 9.59% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
1601
DELISTED
Sprint Corporation
S
| $164K | ﹤0.01% |
36,049
-432,505
| -92% | -$2.08M |
|
1602
Horizon Bancorp
HBNC
$1.03B
| $162K | ﹤0.01% |
14,625
+1,125
| +8% | +$12K |
|
|
BEAT
1603
DELISTED
BioTelemetry, Inc.
BEAT
| $161K | ﹤0.01% |
17,100
+1,200
| +8% | +$11.1K |
|
1604
Mercantile Bank Corp
MBWM
$988M
| $160K | ﹤0.01% |
7,500
-687
| -8% | -$13.9K |
|
1605
Nektar Therapeutics
NKTR
$2.34B
| $160K | ﹤0.01% |
858
| – | – |
|
|
SRNE
1606
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $160K | ﹤0.01% |
+9,100
| New | +$117K |
|
1607
Ardelyx
ARDX
$1.27B
| $159K | ﹤0.01% |
+10,000
| New | +$126K |
|
1608
PTC Therapeutics
PTCT
$6.51B
| $158K | ﹤0.01% |
+3,300
| New | +$193K |
|
|
BCOV
1609
DELISTED
Brightcove, Inc.
BCOV
| $157K | ﹤0.01% |
+23,000
| New | +$162K |
|
1610
Independent Bank Corp
IBCP
$755M
| $154K | ﹤0.01% |
11,400
+800
| +8% | +$10.7K |
|
|
FDO
1611
DELISTED
FAMILY DOLLAR STORES
FDO
| $154K | ﹤0.01% |
1,966
| – | – |
|
1612
OraSure Technologies
OSUR
$277M
| $152K | ﹤0.01% |
28,300
-15,300
| -35% | -$94.5K |
|
1613
PENN Entertainment
PENN
$2.71B
| $152K | ﹤0.01% |
8,300
-57,300
| -87% | -$953K |
|
1614
Littelfuse
LFUS
$10.5B
| $151K | ﹤0.01% |
1,600
| – | – |
|
|
CCRN
1615
DELISTED
Cross Country Healthcare
CCRN
| $149K | ﹤0.01% |
11,800
+800
| +7% | +$9.07K |
|
|
CTT
1616
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $146K | ﹤0.01% |
12,700
+6,400
| +102% | +$75.3K |
|
1617
Silicon Laboratories
SLAB
$7.15B
| $145K | ﹤0.01% |
2,700
-22,300
| -89% | -$1.19M |
|
1618
Virtu Financial
VIRT
$5.19B
| $143K | ﹤0.01% |
+6,100
| New | +$137K |
|
1619
Healthcare Services Group
HCSG
$1.54B
| $142K | ﹤0.01% |
4,300
-1,000
| -19% | -$31.5K |
|
1620
Ionis Pharmaceuticals
IONS
$9.23B
| $141K | ﹤0.01% |
2,453
-30,300
| -93% | -$1.93M |
|
1621
AXIS Capital
AXS
$8.45B
| $140K | ﹤0.01% |
2,635
| – | – |
|
|
ALE
1622
DELISTED
Allete
ALE
| $139K | ﹤0.01% |
3,000
-500
| -14% | -$24.9K |
|
|
DX
1623
Dynex Capital
DX
$2.99B
| $138K | ﹤0.01% |
6,067
| – | – |
|
1624
Valley National Bancorp
VLY
$7.99B
| $138K | ﹤0.01% |
13,400
+1,600
| +14% | +$15.6K |
|
|
TESO
1625
DELISTED
Tesco Corp
TESO
| $138K | ﹤0.01% |
12,700
+6,200
| +95% | +$74.4K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2015 Portfolio in Review
As of Q2 2015, STRS Ohio held 2,075 positions worth $22.8B, up 0.45% from $22.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio's Q2 2015 filing shows 272 new, 822 increased, 479 reduced and 218 closed positions. Its largest new stake was Ingredion: 315,000 shares worth $25.1M. The largest sale was Boston Scientific, an estimated $85M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- STRS Ohio's largest Q2 2015 buy was Ingredion: 315,000 shares worth $25.1M.
- STRS Ohio added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q2 2015, an estimated $58.5M increase.
- STRS Ohio's biggest Q2 2015 reduction was Boston Scientific, cutting an estimated $85M.
- STRS Ohio fully exited Ryder in Q2 2015, selling an estimated $29.3M.
- STRS Ohio's ten largest holdings make up 14% of its $22.8B portfolio in Q2 2015.
- STRS Ohio opened 272 new positions and closed 218 in Q2 2015.
- STRS Ohio's portfolio value rose 0.45% quarter-over-quarter to $22.8B.
Based on STRS Ohio's 13F filing for Q2 2015, filed 4 Aug 2015.